{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:39:29Z","timestamp":1792003169270,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Aldosterone, produced by the adrenals and\u00a0under the\u00a0control of plasma angiotensin and potassium levels, regulates hydromineral homeostasis and blood pressure. Here we report that the neuropeptide substance P (SP) released by intraadrenal nerve fibres, stimulates aldosterone secretion via binding to neurokinin type 1 receptors (NK1R) expressed by aldosterone-producing adrenocortical cells. The action of SP is mediated by the extracellular signal-regulated kinase pathway and involves upregulation of steroidogenic enzymes. We also conducted a prospective proof-of-concept, double blind, placebo-controlled clinical trial aimed to investigate the impact of the NK1R antagonist aprepitant on aldosterone secretion in healthy male volunteers (EudraCT: 2008-003367-40, ClinicalTrial.gov: NCT00977223). Participants received during two 7-day treatment periods aprepitant (125\u2009mg on the 1\n                    <jats:sup>st<\/jats:sup>\n                    day and 80\u2009mg during the following days) or placebo in a random order at a\u00a02-week interval. The primary endpoint was plasma aldosterone levels during posture test. Secondary endpoints included basal aldosterone alterations, plasma aldosterone variation during metoclopramide and hypoglycaemia tests, and basal and stimulated alterations of renin, cortisol and ACTH during the three different stimulatory tests. The safety of the treatment was assessed on the basis of serum transaminase measurements on days 4 and 7. All pre-specified endpoints were achieved. Aprepitant decreases aldosterone production by around 30% but does not influence the aldosterone response to upright posture. These results indicate that the autonomic nervous system exerts a direct stimulatory tone on mineralocorticoid synthesis through SP, and thus plays a role in the maintenance of hydromineral homeostasis. This regulatory mechanism may be involved in aldosterone excess syndromes.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-16470-8","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T06:02:27Z","timestamp":1590732147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The neuropeptide substance P regulates aldosterone secretion in human adrenals"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6651-0527","authenticated-orcid":false,"given":"Julien","family":"Wils","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7301-6287","authenticated-orcid":false,"given":"C\u00e9line","family":"Duparc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Fran\u00e7oise","family":"Cailleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-8693","authenticated-orcid":false,"given":"Antoine-Guy","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Guiheneuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Boutelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadrien-Ga\u00ebl","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9252-0959","authenticated-orcid":false,"given":"Christophe","family":"Dubessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3194-1885","authenticated-orcid":false,"given":"Saloua","family":"Cherifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Cauliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Gobet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Defortescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4723-095X","authenticated-orcid":false,"given":"Estelle","family":"Louiset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6181-9648","authenticated-orcid":false,"given":"Herv\u00e9","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"16470_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.mce.2011.07.034","volume":"350","author":"NG Hattangady","year":"2012","unstructured":"Hattangady, N. G., Olala, L. O., Bollag, W. B. & Rainey, W. E. Acute and chronic regulation of aldosterone production. Mol. Cell. Endocrinol. 350, 151\u2013162 (2012).","journal-title":"Mol. Cell. Endocrinol."},{"key":"16470_CR2","first-page":"1110","volume":"304","author":"J Staessen","year":"1981","unstructured":"Staessen, J., Lijnen, P., Fagard, R., Verschueren, L. J. & Amery, A. Rise of plasma aldosterone during long-term captopril treatment. N. Engl. J. Med. 304, 1110 (1981).","journal-title":"N. Engl. J. Med."},{"key":"16470_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jash.2012.07.003","volume":"6","author":"AS Bomback","year":"2012","unstructured":"Bomback, A. S. et al. Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy. J. Am. Soc. Hypertens. 6, 338\u2013345 (2012).","journal-title":"J. Am. Soc. Hypertens."},{"key":"16470_CR4","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1007\/s00125-004-1542-0","volume":"47","author":"KJ Schjoedt","year":"2004","unstructured":"Schjoedt, K. J., Andersen, S., Rossing, P., Tarnow, L. & Parving, H.-H. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia 47, 1936\u20131939 (2004).","journal-title":"Diabetologia"},{"key":"16470_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/147323000102900103","volume":"29","author":"A Sato","year":"2001","unstructured":"Sato, A. & Saruta, T. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy. J. Int. Med. Res. 29, 13\u201321 (2001).","journal-title":"J. Int. Med. Res."},{"key":"16470_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1210\/edrv.19.2.0326","volume":"19","author":"M Ehrhart-Bornstein","year":"1998","unstructured":"Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A. & Vinson, G. P. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr. Rev. 19, 101\u2013143 (1998).","journal-title":"Endocr. Rev."},{"key":"16470_CR7","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1530\/EJE-13-0308","volume":"169","author":"H Lefebvre","year":"2013","unstructured":"Lefebvre, H., Pr\u00e9vost, G. & Louiset, E. Autocrine\/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism. Eur. J. Endocrinol. 169, R115\u2013138 (2013).","journal-title":"Eur. J. Endocrinol."},{"key":"16470_CR8","first-page":"501","volume":"180","author":"BG Charlton","year":"1992","unstructured":"Charlton, B. G., McGadey, J., Russell, D. & Neal, D. E. Noradrenergic innervation of the human adrenal cortex as revealed by dopamine-beta-hydroxylase immunohistochemistry. J. Anat. 180, 501\u2013506 (1992).","journal-title":"J. Anat."},{"key":"16470_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000147417","volume":"146","author":"AB Gilchrist","year":"1993","unstructured":"Gilchrist, A. B., Leake, A. & Charlton, B. G. Innervation of the human adrenal cortex: simultaneous visualisation using acetylcholinesterase histochemistry and dopamine beta-hydroxylase immunohistochemistry. Acta Anat. 146, 31\u201335 (1993).","journal-title":"Acta Anat."},{"key":"16470_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/BF01835156","volume":"104","author":"C Heym","year":"1995","unstructured":"Heym, C., Braun, B., Shuyi, Y., Klimaschewski, L. & Colombo-Benkmann, M. Immunohistochemical correlation of human adrenal nerve fibres and thoracic dorsal root neurons with special reference to substance P. Histochem. Cell Biol. 104, 233\u2013243 (1995).","journal-title":"Histochem. Cell Biol."},{"key":"16470_CR11","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1126\/science.286.5444.1558","volume":"286","author":"ML Nichols","year":"1999","unstructured":"Nichols, M. L. et al. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 286, 1558\u20131561 (1999).","journal-title":"Science"},{"key":"16470_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1152\/physrev.00031.2013","volume":"94","author":"MS Steinhoff","year":"2014","unstructured":"Steinhoff, M. S., von Mentzer, B., Geppetti, P., Pothoulakis, C. & Bunnett, N. W. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. Physiol. Rev. 94, 265\u2013301 (2014).","journal-title":"Physiol. Rev."},{"key":"16470_CR13","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0140-6736(17)30823-1","volume":"389","author":"JK Prague","year":"2017","unstructured":"Prague, J. K. et al. Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 389, 1809\u20131820 (2017).","journal-title":"Lancet"},{"key":"16470_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1254\/jphs.91.87","volume":"91","author":"R Saito","year":"2003","unstructured":"Saito, R., Takano, Y. & Kamiya, H.-O. Roles of substance P and NK(1) receptor in the brainstem in the development of emesis. J. Pharmacol. Sci. 91, 87\u201394 (2003).","journal-title":"J. Pharmacol. Sci."},{"key":"16470_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1677\/joe.0.1400091","volume":"140","author":"JP Hinson","year":"1994","unstructured":"Hinson, J. P., Cameron, L. A., Purbrick, A. & Kapas, S. The role of neuropeptides in the regulation of adrenal zona glomerulosa function: effects of substance P, neuropeptide Y, neurotensin, Met-enkephalin, Leu-enkephalin and corticotrophin-releasing hormone on aldosterone secretion in the intact perfused rat adrenal. J. Endocrinol. 140, 91\u201396 (1994).","journal-title":"J. Endocrinol."},{"key":"16470_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0143-4179(95)90056-X","volume":"29","author":"G Mazzocchi","year":"1995","unstructured":"Mazzocchi, G., Macchi, C., Malendowicz, L. K. & Nussdorfer, G. G. Evidence that endogenous substance-P (SP) is involved in the maintenance of the growth and steroidogenic capacity of rat adrenal zona glomerulosa. Neuropeptides 29, 53\u201358 (1995).","journal-title":"Neuropeptides"},{"key":"16470_CR17","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1164\/ajrccm.158.supplement_2.13tac140","volume":"158","author":"JG Widdicombe","year":"1998","unstructured":"Widdicombe, J. G. Autonomic regulation. i-NANC\/e-NANC. Am. J. Respir. Crit. Care Med. 158, S171\u2013175 (1998).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"16470_CR18","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1073\/pnas.0931458100","volume":"100","author":"NM Page","year":"2003","unstructured":"Page, N. M. et al. Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc. Natl Acad. Sci. USA 100, 6245\u20136250 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16470_CR19","doi-asserted-by":"publisher","first-page":"e0205894","DOI":"10.1371\/journal.pone.0205894","volume":"13","author":"NMJ Rupniak","year":"2018","unstructured":"Rupniak, N. M. J. et al. Affinity, potency, efficacy, and selectivity of neurokinin A analogs at human recombinant NK2 and NK1 receptors. PLoS ONE 13, e0205894 (2018).","journal-title":"PLoS ONE"},{"key":"16470_CR20","doi-asserted-by":"publisher","first-page":"27773","DOI":"10.1074\/jbc.M603369200","volume":"281","author":"GS Cottrell","year":"2006","unstructured":"Cottrell, G. S. et al. Ubiquitin-dependent down-regulation of the neurokinin-1 receptor. J. Biol. Chem. 281, 27773\u201327783 (2006).","journal-title":"J. Biol. Chem."},{"key":"16470_CR21","doi-asserted-by":"publisher","first-page":"10691","DOI":"10.1073\/pnas.0703394104","volume":"104","author":"MF Tansky","year":"2007","unstructured":"Tansky, M. F., Pothoulakis, C. & Leeman, S. E. Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor. Proc. Natl Acad. Sci. USA 104, 10691\u201310696 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16470_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","volume":"383","author":"CE Gomez-Sanchez","year":"2014","unstructured":"Gomez-Sanchez, C. E. et al. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol. Cell. Endocrinol. 383, 111\u2013117 (2014).","journal-title":"Mol. Cell. Endocrinol."},{"key":"16470_CR23","doi-asserted-by":"publisher","first-page":"12605","DOI":"10.1073\/pnas.0806632105","volume":"105","author":"J-P Lai","year":"2008","unstructured":"Lai, J.-P. et al. Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor. Proc. Natl Acad. Sci. USA 105, 12605\u201312610 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16470_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1055\/s-0031-1284367","volume":"119","author":"K Vleugels","year":"2011","unstructured":"Vleugels, K. et al. ERK1\/2 MAPKs and Wnt signaling pathways are independently involved in adipocytokine-mediated aldosterone secretion. Exp. Clin. Endocrinol. Diabetes 119, 644\u2013648 (2011).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"16470_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nm.2061","volume":"16","author":"M Doi","year":"2010","unstructured":"Doi, M. et al. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat. Med. 16, 67\u201374 (2010).","journal-title":"Nat. Med."},{"key":"16470_CR26","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1200\/JCO.2017.74.4789","volume":"35","author":"PJ Hesketh","year":"2017","unstructured":"Hesketh, P. J. et al. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. J. Clin. Oncol. 35, 3240\u20133261 (2017).","journal-title":"J. Clin. Oncol."},{"key":"16470_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1159\/000126262","volume":"56","author":"V Coiro","year":"1992","unstructured":"Coiro, V. et al. Stimulation of ACTH\/cortisol by intravenously infused substance P in normal men: inhibition by sodium valproate. Neuroendocrinology 56, 459\u2013463 (1992).","journal-title":"Neuroendocrinology"},{"key":"16470_CR28","doi-asserted-by":"crossref","first-page":"AP180","DOI":"10.1161\/hyp.68.suppl_1.p180","volume":"68","author":"S Hubers","year":"2016","unstructured":"Hubers, S., Wei, S. & Brown, N. Quantification of substance P in human blood by mass spectroscopy. Hypertension 68, AP180 (2016).","journal-title":"Hypertension"},{"key":"16470_CR29","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1210\/endo.133.5.7691584","volume":"133","author":"F Leboulenger","year":"1993","unstructured":"Leboulenger, F. et al. Immunohistochemical distribution, biochemical characterization, and biological action of tachykinins in the frog adrenal gland. Endocrinology 133, 1999\u20132008 (1993).","journal-title":"Endocrinology"},{"key":"16470_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0960-0760(91)90205-J","volume":"40","author":"JP Hinson","year":"1991","unstructured":"Hinson, J. P., Vinson, G. P., Kapas, S. & Teja, R. The relationship between adrenal vascular events and steroid secretion: the role of mast cells and endothelin. J. Steroid Biochem. Mol. Biol. 40, 381\u2013389 (1991).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"16470_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/jhh.2011.47","volume":"26","author":"T Dudenbostel","year":"2012","unstructured":"Dudenbostel, T. & Calhoun, D. A. Resistant hypertension, obstructive sleep apnoea and aldosterone. J. Hum. Hypertens. 26, 281\u2013287 (2012).","journal-title":"J. Hum. Hypertens."},{"key":"16470_CR32","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1210\/jc.2018-00866","volume":"103","author":"Y Ohno","year":"2018","unstructured":"Ohno, Y. et al. Obesity as a key factor underlying idiopathic hyperaldosteronism. J. Clin. Endocrinol. Metab. 103, 4456\u20134464 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"16470_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11906-009-0036-3","volume":"11","author":"AA da Silva","year":"2009","unstructured":"da Silva, A. A., do Carmo, J., Dubinion, J. & Hall, J. E. The role of the sympathetic nervous system in obesity-related hypertension. Curr. Hypertens. Rep. 11, 206\u2013211 (2009).","journal-title":"Curr. Hypertens. Rep."},{"key":"16470_CR34","first-page":"243","volume":"8","author":"V Bisogni","year":"2016","unstructured":"Bisogni, V., Pengo, M. F., Maiolino, G. & Rossi, G. P. The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea. J. Thorac. Dis. 8, 243\u2013254 (2016).","journal-title":"J. Thorac. Dis."},{"key":"16470_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.02898.x","volume":"67","author":"P Mulatero","year":"2007","unstructured":"Mulatero, P., Verhovez, A., Morello, F. & Veglio, F. Diagnosis and treatment of low-renin hypertension. Clin. Endocrinol. 67, 324\u2013334 (2007).","journal-title":"Clin. Endocrinol."},{"key":"16470_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrneph.2010.30","volume":"6","author":"M Briet","year":"2010","unstructured":"Briet, M. & Schiffrin, E. L. Aldosterone: effects on the kidney and cardiovascular system. Nat. Rev. Nephrol. 6, 261\u2013273 (2010).","journal-title":"Nat. Rev. Nephrol."},{"key":"16470_CR37","doi-asserted-by":"crossref","unstructured":"Gorini, S., Marzolla, V., Mammi, C., Armani, A. & Caprio, M. Mineralocorticoid receptor and aldosterone-related biomarkers of end-organ damage in cardiometabolic disease. Biomolecules 8, E96 (2018).","DOI":"10.3390\/biom8030096"},{"key":"16470_CR38","first-page":"469","volume":"6","author":"A Mosenkis","year":"2004","unstructured":"Mosenkis, A. & Townsend, R. R. Gynecomastia and antihypertensive therapy. J. Clin. Hypertens. 6, 469\u2013470 (2004).","journal-title":"J. Clin. Hypertens."},{"key":"16470_CR39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ando.2016.01.010","volume":"77","author":"A Pech\u00e8re-Bertschi","year":"2016","unstructured":"Pech\u00e8re-Bertschi, A., Herpin, D. & Lefebvre, H. SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 7: Medical treatment of primary aldosteronism. Ann. Endocrinol. 77, 226\u2013234 (2016).","journal-title":"Ann. Endocrinol."},{"key":"16470_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/ndt\/gfs388","volume":"28","author":"M Azizi","year":"2013","unstructured":"Azizi, M., Amar, L. & Menard, J. Aldosterone synthase inhibition in humans. Nephrol. Dial. Transplant. 28, 36\u201343 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"key":"16470_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/0091270005283467","volume":"46","author":"AK Majumdar","year":"2006","unstructured":"Majumdar, A. K. et al. Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteers. J. Clin. Pharmacol. 46, 291\u2013300 (2006).","journal-title":"J. Clin. Pharmacol."},{"key":"16470_CR42","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/gut.47.5.667","volume":"47","author":"AE Bharucha","year":"2000","unstructured":"Bharucha, A. E. et al. Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut 47, 667\u2013674 (2000).","journal-title":"Gut"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16470-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16470-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16470-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:29:11Z","timestamp":1670261351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16470-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["16470"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-16470-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]},"assertion":[{"value":"15 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.L. received payment from MSD Laboratories for lecture unrelated to this study. J.W., C.D., A.-G.L., I.B., H.-G.B., C.D., S.C., F.G. and E.L declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2673"}}